Shen Lim: Latest News

Babies and toddlers who are clinically vulnerable to coronavirus should be offered a vaccine, the Joint Committee on Vaccination and Immunisation (JCVI) has advised.

for the COVID-19 vaccine programme in autumn this year.Similar to previous spring and autumn campaigns, the Committee’s advice is to offer the vaccine to those at high risk of serious disease and who are therefore most likely to benefit from vaccination.Vaccination continues to help protect against severe illness, hospitalisations and deaths arising from COVID-19.JCVI advises the following groups be offered a COVID-19 vaccine this autumn:adults aged 65 years and overresidents in a care home for older adultsindividuals aged 6 months to 64 years in a clinical risk group ()The vaccine should usually be offered no earlier than around 6 months after the last vaccine dose.Professor Wei Shen Lim, Chair of JCVI’s COVID-19 immunisation group, said:The COVID-19 autumn programme will continue to focus on those at greatest risk of getting seriously ill. These people will benefit the most from a further vaccine dose.It is important that everyone who is eligible takes up the offer before we head into winter.

Health officials have announced that the number of people to receive the Covid-19 booster jab in the autumn will be reduced.

The Joint Committee on Vaccine and Immunisation (JVCI) has recommended that the government provides an autumn Covid-19 booster programme in preparation for winter.

A fourth coronavirus jab may be needed to improve levels of protection, a vaccine boss has said.

A decision on vaccinating children aged five to 11 could be reached in the next 10 days, according to the head of the UK's vaccine advisory group.

Get the day's biggest stories sent direct to your inbox so you never miss a thing

AstraZeneca coronavirus vaccine if another shot is available because of a link to extremely rare blood clots, the government said Friday. It said the change would not affect the goal of giving all U.K.

LONDON – People under 40 in Britain will not be given the Oxford-AstraZeneca coronavirus vaccine if another shot is available because of a link to extremely rare blood clots, the government said Friday. It said the change would not affect the goal of giving all U.K. adults at least one vaccine dose by July.

direct to your inboxProfessor Jonathan Van-Tam led a Downing Street briefing on the potential coronavirus vaccine on Wednesday morning.Following the successful news that the Pfizer/BioNTech Covid-19 vaccine interim results show that it's 90 per cent effective, many questions have been raised about the likely roll out.The UK has secured 30 million doses of the Pfizer/BioNTech vaccine – the first agreement the firms signed with any government.But is thought people will need two doses, meaning not enough shots have been secured for the entire UK population.